Controlled release of bioactive TGF-beta 1 from microspheres embedded within biodegradable hydrogels

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Tissue Engineering

Background:

• Transforming growth factor-beta1 (TGF-beta1) is crucial for cartilage development and regeneration.
• Developing controlled delivery systems for growth factors like TGF-beta1 is key for effective cartilage repair therapies.
• Current methods may lack precise control over growth factor release kinetics.

Purpose of the Study:

• To create and evaluate a novel drug delivery system for controlled release of TGF-beta1 for cartilage regeneration.
• To investigate the encapsulation of TGF-beta1 within poly(DL-lactide-co-glycolide) (PLGA) microspheres and their incorporation into biodegradable hydrogels.
• To assess the release kinetics and bioactivity of TGF-beta1 from the developed hydrogel-microsphere system.

Main Methods:

• Encapsulation of TGF-beta1 into PLGA microspheres.
• Incorporation of microspheres into poly(ethylene glycol)-based hydrogels crosslinked with genipin.
• Assessment of TGF-beta1 release kinetics using ELISA.
• Evaluation of released TGF-beta1 bioactivity via a mink lung cell growth inhibition assay.

Main Results:

• The hydrogel-microsphere system demonstrated better controlled release of TGF-beta1 compared to microspheres alone.
• TGF-beta1 release was sustained over 21 days with reduced burst release when microspheres were embedded in hydrogels.
• Release concentration of TGF-beta1 could be modulated by microsphere mass and genipin concentration.
• The scaffold structure facilitated containment and conformation of microspheres to defect shapes.

Conclusions:

• The microsphere-loaded hydrogel system offers a promising approach for controlled TGF-beta1 delivery to cartilage wound sites.
• This system provides enhanced control over growth factor release kinetics and bioactivity.
• Further in vivo studies are warranted to validate the therapeutic potential for cartilage repair.